Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 40Terminated 18Unknown 13Recruiting 10Active not recruiting 6Withdrawn 3Not yet recruiting 3Suspended 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Neoplasms 17Breast Neoplasms 14Rectal Neoplasms 13Nasopharyngeal Carcinoma 8Stomach Neoplasms 5Triple Negative Breast Neoplasms 3Colonic Neoplasms 3Cholangiocarcinoma 3Carcinoma, Hepatocellular 3Biliary Tract Neoplasms 3Adenocarcinoma 3Recurrence 2Pancreatic Neoplasms 2HER2-positive Gastric Cancer 2Carcinoma, Non-Small-Cell Lung 2Spinocerebellar Degenerations 1Rectal Neoplasms Malignant 1Rectal Cancer Patients 1Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal Cancer 1Pathologic Complete Response 1Pancreatic Cancer Resectable 1Pancreatic Cancer Non-resectable 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Nasopharyngeal Cancinoma (NPC) 1Mouth Neoplasms 1Metastatic Breast Cancer in the Brain 1MSI-H Colorectal Cancer 1Locally Advanced Rectal Cancer (LARC) 1Locally Advanced Rectal Cancer 1

Interventions

Oxaliplatin 6tislelizumab 3Irinotecan 3Fluorouracil 3Chemotherapy, Adjuvant 3Capecitabine 3sintilimab 2raltitrexed 2pembrolizumab 2Surgical Procedures, Operative 2Specimen Handling 2Neoadjuvant Therapy 2HMPL-013 2spartalizumab 1rimegepant sulfate 1encorafenib 1cemiplimab 1balstilimab 1XELOX 1Surgical Fixation Devices 1Radiofrequency Ablation 1Propranolol 1Preoperative Exercise 1Pemetrexed 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Mortality 1Magnetic Resonance Spectroscopy 1Leucovorin 1Laparoscopy 1Immune Checkpoint Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Colonic Neoplasms × Capecitabine × Clear all
NCT07549906 2026-04-24

Neoadjuvant Iparomlimab/Tuvonralimab Plus CAPEOX Versus Iparomlimab/Tuvonralimab Plus CAPEOX and Propranolol for Locally Advanced pMMR Colon Cancer: A Prospective, Single-Center, Multi-Cohort Study

Sun Yat-sen University

Phase 2 Not yet recruiting
45 enrolled
Gastrointestinal

Colonic Neoplasms

NCT07132008 2025-08-20

Neoadjuvant CAPOX Plus Tislelizumab vs CAPOX in MSS High-Risk Locally Advanced Colon Cancer

First Affiliated Hospital of Guangxi Medical University

Phase 3 Not yet recruiting
94 enrolled
Gastrointestinal

Colonic Neoplasms

NCT06790212 2025-03-17

Neoadjuvant CAPOX Plus Ivonescimab Versus CAPOX for Locally Advanced Colon Cancer

Sun Yat-sen University

Phase 2 Not yet recruiting
168 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡